These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15257732)

  • 1. Only one of four patients with familial hypercholesterolaemia reach cholesterol treatment goals in primary prevention.
    Hollman G; Ek AC; Olsson AG
    J Intern Med; 2004 Aug; 256(2):176-7. PubMed ID: 15257732
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG; Goldberg AC;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S18-29. PubMed ID: 21600526
    [No Abstract]   [Full Text] [Related]  

  • 4. Arterial abnormalities in children with familial hypercholesterolaemia.
    Raitakari OT
    Lancet; 2004 Jan; 363(9406):342-3. PubMed ID: 15070559
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of familial hypercholesterolaemia.
    Meher D; Dutta D; Misgar RA
    Postgrad Med J; 2016 May; 92(1087):304-5. PubMed ID: 26739848
    [No Abstract]   [Full Text] [Related]  

  • 8. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
    Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
    J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New EAS Consensus Statement on FH: improving the care of FH patients.
    Stock J
    Atherosclerosis; 2013 Nov; 231(1):69-71. PubMed ID: 24125413
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial hypercholesterolaemia: A guide for general practice.
    Brett T; Arnold-Reed D
    Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
    Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
    Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
    [No Abstract]   [Full Text] [Related]  

  • 14. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apheresis in severe hypercholesterolaemia].
    Graesdal A; Hovland A; Bjørbaek E
    Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is the detection of familial hypercholesterolemia in children indicated? Occasionally, yes].
    Gevers Leuven JA
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2551-4. PubMed ID: 9555155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.